ArticleBMC cancer2025

Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma.

Yusuke Toyohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.